Onconova Therapeutics Inc
For the period ended Dec 31, 2023. Filed Apr 1, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Apr 1, 2024
TRAW$0.23-6.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 15. : Exhibits, Financial Statement Schedules
**ITEM 15.**EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
| (a) | (1) Financial Statements: See Index to Consolidated Financial Statements on page F-1. |
| (3) | Exhibits: See Exhibits Index on pages 61 to 65 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.